NeuroVision Imaging

About:

NeuroVision Imaging is a developer of digital imaging and diagnostic solutions for Alzheimer's disease.

Top Investors: Omega Funds, Johnson & Johnson Innovation – JJDC, Alzheimer's Drug Discovery Foundation, Wildcat Capital Management, VSP Global

Description:

NeuroVision is an integrated neuroscience company focused on delivering scientifically validated, diagnostic tests & biomarkers for early detection and monitoring of amyloid pathology related to Alzheimer’s Disease. The company has developed a novel retinal imaging technology, which is currently being utilized in a number of clinical trials globally.With access to unique datasets, we provide data aggregation services, analysis, biostatistics, and applications of machine learning algorithms to large repositories of images and other biomarker data seeking to advance the collective understanding and prediction capabilities for neurodegenerative diseases.

Total Funding Amount:

$21.2M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Sacramento, California, United States

Founded Date:

2010-01-01

Founders:

Keith L. Black, Maya Koronyo- Hamaoui, Steven R. Verdooner, Yosef Koronyo

Number of Employees:

1-10